Format

Send to

Choose Destination
See comment in PubMed Commons below
J Dermatol Sci. 1999 Dec;22(1):1-10.

CD19 is a central response regulator of B lymphocyte signaling thresholds governing autoimmunity.

Author information

  • 1Department of Dermatology, Kanazawa University School of Medicine, Ishikawa, Japan. s-sato@med.kanazawa-u.ac.jp

Abstract

The CD19/CD21 complex is categorized among the 'response regulator' class of receptors which determine the magnitude and outcomes of B cell receptor signals. Small changes in CD19 expression have dramatic effects on signaling thresholds within B cells, which in turn has considerable impact on the balance between humoral immune responses and tolerance induction. B cell signaling thresholds lowered by increased CD19 expression may significantly augment host susceptibility to the development of autoimmunity. Signals generated by C3d-antigen complex binding to CD21 may also be involved in the development of autoimmunity by regulating CD19 function. Since CD19 serves as a central regulator of signaling thresholds in B cells, the CD19/CD21 complex may be an appropriate target for suppressing the development of autoimmunity.

PMID:
10651223
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk